m6A-centered Drug Response Information
General Information of the Drug (ID: M6ADRUG0203)
| Name |
Marasviroc
|
||||
|---|---|---|---|---|---|
| Formula |
C41H52N4O4S
|
||||
| InChI |
InChI=1S/C41H52N4O4S/c1-5-7-22-48-23-24-49-38-15-10-32(11-16-38)33-12-19-40-35(25-33)26-34(9-8-21-44(40)28-31(3)4)41(46)43-36-13-17-39(18-14-36)50(47)29-37-27-42-30-45(37)20-6-2/h10-19,25-27,30-31H,5-9,20-24,28-29H2,1-4H3,(H,43,46)/b34-26+/t50-/m0/s1
|
||||
| InChIKey |
PNDKCRDVVKJPKG-WHERJAGFSA-N
|
||||
| DrugBank ID | |||||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Drug
| In total 1 item(s) under this drug | ||
| Crosstalk ID: M6ACROT05993 | ||
| m6A Regulator | Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) | |
| m6A Target | Zinc finger protein 281 (ZNF281) | |
| Epigenetic Regulator | Small nucleolar RNA host gene 5 (SNHG5) | |
| Regulated Target | Insulin like growth factor 2 mRNA binding protein 2 (IGF2BP2) | |
| Crosstalk relationship | ncRNA → m6A | |
| Disease | Breast cancer | |